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Importance  
Campylobacter spp., particularly C. jejuni and C. coli, are a major cause of 
enteritis in humans. Additional species cause reproductive disease in sheep and cattle. 
Many animals carry Campylobacter spp. asymptomatically and shed the organism in 
their feces. Poultry, particularly broiler chickens, are an especially important source 
of the bacterium, though they usually do not become ill (www.campypoultry.org). 
Numerous strategies have been explored to decrease colonization of poultry on the 
farm; however, none have been proven to reduce Campylobacter prevalence in broiler 
flocks. 
The major routes of transmission in humans are consumption of contaminated or 
undercooked meat (especially poultry), unpasteurized milk or dairy products, and 
untreated water. People can also be infected by contact with infected animals or feces. 
Campylobacteriosis in humans ranges from mild to severe, but most cases are self-
limiting. Although complications are uncommon, C. jejuni is a major triggering event 
for Guillain-Barré syndrome. C. fetus is an opportunistic human pathogen and mainly 
causes systemic infections in people with compromised immune systems. Antibiotic 
resistance in Campylobacter spp. is a serious problem worldwide, particularly for 
fluoroquinolones and tetracyclines.  
Etiology 
Campylobacter are Gram negative, microaerophilic, curved or spiral rods in the 
family Campylobacteriaceae. Campylobacter jejuni and C. coli are the major 
Campylobacter species associated with enteritis in domesticated animals and humans. 
Some strains of C. jejuni, C. fetus subsp. venerealis, and C. fetus subsp. fetus (also 
known as C. fetus) cause infertility and abortions in ruminants. C. fetus is 
occasionally isolated from humans with septicemia. Additional zoonotic species 
include C. helveticus, C. hyointestinalis, C. lari, C. upsaliensis, C. sputorum, and C. 
ureolyticus. 
Species that have been associated only with disease in humans to-date include C. 
concisus and C. curvus (gastroenteritis, periodontitis); C. gracilis C. rectus, and C. 
showae (periodontitis); C. jejuni subsp. doylei (septicemia, enteritis); and C. lari 
subsp. concheus and C. peloridis (enteritis). 
Species Affected 
Campylobacter spp. are ubiquitous; they are found in humans and many animal 
species, although some clonal complexes are more commonly associated with certain 
hosts. C. jejuni and C. coli can infect cattle, sheep, chickens, turkeys, dogs, cats, 
mink, ferrets, pigs, non-human primates and other species. Other species of 
Campylobacter can cause disease but seem to be of minor importance in domesticated 
animals. These include C. lari, C. hyointestinalis, C. helveticus, and C. upsaliensis. C. 
fetus subsp. fetus has been found in cattle, sheep and goats, while C. fetus subsp. 
venerealis has been reported in cattle. Birds and reptiles can also be affected by some 
species. 
Zoonotic Potential 
Humans are susceptible to infection with multiple Campylobacter spp.; the major 
human pathogens are C. jejuni (enteritis) and C. fetus (septicemia). Additional 
species, such as C. lari, C. upsaliensis, and C. hyointestinalis have been less 
commonly detected in humans. Unlike animals, humans do not usually become long 
term carriers of the bacterium.  
Geographic Distribution 
C. jejuni, C. coli and C. fetus infections are found worldwide.  
Transmission 
Campylobacter jejuni and C. coli are transmitted by the fecal-oral route. 
Contaminated or undercooked poultry and other meats are sources of infection for 
carnivores such as pets and commercially raised mink. C. jejuni may also be present 
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in the vaginal discharges, aborted fetuses and fetal 
membranes of aborting sheep. Wild rodents and insects 
such as houseflies may be mechanical vectors 
Campylobacter fetus subsp. fetus is transmitted by 
ingestion in cattle, sheep and goats. Animals can become 
infected after contact with feces, vaginal discharges, 
aborted fetuses and fetal membranes. This organism and 
C. fetus subsp. venerealis are also transmitted venereally 
in cattle. Genital C. fetus infections can be spread on 
fomites including contaminated semen, contaminated 
instruments and bedding. Bulls may transmit C. fetus for 
several hours after being bred to an infected cow; some 
bulls can become permanent carriers. Cows can also 
become carriers for years. 
Campylobacter species do not tolerate drying or 
heating but can often survive for a time in moist 
environments. Campylobacter can survive for weeks in 
water at 4°C (39°F), but only a few days in water above 
15°C (59°F). C. jejuni may remain viable for up to 9 days 
in feces, 3 days in milk and 2 to 5 days in water. C. jejuni 
and C. coli can remain infective in moist poultry litter for 
prolonged periods. C. fetus can survive in liquid manure for 
24 hours and soil for up to 20 days. 
Humans are infected most commonly after the 
ingestion of contaminated or undercooked meat (especially 
poultry), raw milk or other dairy products, and other 
contaminated foods such as unwashed vegetables. 
Untreated water is another potential source of infection. 
Campylobacter spp. are also transmitted to humans through 
contact with infected pets or livestock.  
Additionally, Campylobacter spp. can spread person-
to-person (direct or indirect fecal-oral). This occurs 
through sexual activity, and has also been reported in 
young children with diarrhea in day-care centers. C. jejuni 
can be shed in the feces for as long as 2 to 7 weeks in 
untreated infections; however, humans rarely become 
chronic carriers. C. fetus subsp. fetus is communicable for 
several days to several weeks. Homosexual men are at 
increased risk of infection with atypical Campylobacter 
species.  
Disinfection 
Campylobacter species are susceptible to many 
disinfectants. C. jejuni and C. coli can be inactivated by 
iodophors, quaternary ammonium compounds, phenolic 
compounds, 70% ethyl alcohol and glutaraldehyde. 
Hypochlorite (5mg/L) is also effective. Additionally, C. 
coli is susceptible to >1.5% NaCL and pH extremes (<5.0 
and >9.0). C. jejuni and C. coli both are inactivated by 
heat (70°C [158°F] for one minute) and hydrostatic 
pressure (450 MPa at 15°C [59°F] for 30 seconds). C. 
jejuni has also been shown to be sensitive to gamma 
irradiation. 
 
Infections in Animals 
Incubation Period 
The incubation period for Campylobacter infections is 
generally short. Signs of enteritis appear within 3 days in 
gnotobiotic puppies and rapidly in chicks and poults. 
Clinical Signs 
Many healthy animals can carry Campylobacter spp. 
asymptomatically. Campylobacter spp. also cause enteritis, 
abortions and infertility in various species. 
Enteritis 
C. jejuni and occasionally C. coli cause enteritis in 
dogs, cats, calves, sheep, mink, ferrets, poultry, pigs and 
some species of laboratory animals. The clinical signs may 
be more severe in young animals, such as kittens, puppies 
or calves. Dogs may have diarrhea, decreased appetite, 
vomiting and sometimes fever. The feces are usually watery 
or bile-streaked, with mucus and sometimes blood. The 
clinical signs generally last 3 to 7 days, but some animals 
may have intermittent diarrhea for weeks and occasionally 
for months. Calves typically have a thick, mucoid diarrhea 
with occasional flecks of blood, either with or without a 
fever. Mucoid, watery and sometimes bloody diarrhea is 
also seen in cats, primates, mink, ferrets, hamsters, guinea 
pigs, mice and rats. Poultry have an especially high rate of 
colonization, though most develop no signs of disease. 
Newly hatched chicks and poults can reportedly develop 
acute enteritis, with rapid onset of diarrhea and death; 
however, disease has not been replicated experimentally. C. 
jejuni has been isolated from ostriches with enteritis and 
may cause death in young birds.  
Reproductive signs  
In cattle, C. fetus subsp. venerealis and C. fetus subsp. 
fetus can cause bovine genital campylobacteriosis; this 
disease is characterized by infertility, early embryonic death 
and a prolonged calving season. Abortions are uncommon 
but are occasionally seen. Infected cows may develop a 
mucopurulent endometritis but do not usually have other 
systemic signs. Bulls are asymptomatic.  
C. jejuni has recently become the predominant cause of 
sheep abortion in the U.S.; C. fetus subsp. fetus also causes 
late term abortions, stillbirths and weak lambs in this 
species. Infections in sheep are sometimes followed by 
metritis and occasionally deaths. Recovery, with immunity 
to reinfection, is typical. Sheep can become persistently 
infected and continue to shed bacteria in the feces. 
Campylobacter spp. can also cause abortion in goats.  
There is limited evidence of reproductive signs in other 
ruminants, though this is likely complicated by a lack of 
testing and reporting in these species. Campylobacter fetus 
subsp. venerealis has been isolated from cervical swabs in 
infertile camels. Campylobacter-associated abortion  
Campylobacteriosis 
Last Updated: November 2013 © 2013 page 3 of 8 
(C. fetus subsp. fetus) has been described in alpacas 
(Vicugna pacos) that were comingled with sheep.  
C. jejuni is also known to cause abortion in cattle and 
sheep. 
Other Campylobacter infections 
Other species of Campylobacter can cause disease but 
seem to be of minor importance in domestic animals. These 
include C. lari, C. hyointestinalis, C. helveticus, and C. 
upsaliensis, which have been associated with gastroenteritis 
in animals. Uncharacterized Campylobacter species may be 
involved in proliferative ileitis of hamsters, porcine 
proliferative enteritis, and proliferative colitis of ferrets. 
Post Mortem Lesions      Click to view images 
In dogs, the colon may be congested and edematous. In 
calves, the lesions may include mild to severe hemorrhagic 
colitis and edematous mesenteric lymph nodes. In chicks, 
distention of the jejunum, disseminated hemorrhagic 
enteritis and focal hepatitis may be seen. 
Aborted cattle fetuses may have bronchopneumonia, 
mild fibrinous pleuritis or peritonitis. Placentitis is usually 
mild; the cotyledons may be hemorrhagic and the 
intercotyledonary area edematous. In sheep, the fetus is 
usually autolyzed after C. fetus abortions; 1–2 cm 
orange/yellow necrotic foci can sometimes be found in the 
liver. Placentitis may be evident, with hemorrhagic necrotic 
cotyledons and edematous or leathery areas between the 
cotyledons. 
Diagnostic Tests 
A presumptive diagnosis can be made by observing the 
characteristic darting motility of Campylobacter spp. in 
darkfield or phase contrast preparations. Gram negative, 
curved or spiral rods are seen in Gram stained preparations. 
Enteritis 
Enteritis can be diagnosed by isolating the causative 
organism in fresh fecal samples; however, Campylobacter 
is fragile and cannot always be found. A variety of media 
can be used for culture, and colony appearance varies 
accordingly.  
Biochemical testing, antigen testing and restriction 
endonuclease DNA analyses have previously been used for 
species and strain identification. Polymerase chain reaction 
(PCR) assays are now the most widely used diagnostic tool 
in most laboratories. Gene sequencing (e.g., 16S rRNA, 
multi locus sequence typing, etc.) is also employed for 
epidemiological typing and identification. Serology on 
paired titers may be helpful in some cases. 
Reproductive syndromes 
Darkfield and phase contrast preparations of samples 
from the placenta, fetal abomasum and uterine discharge 
are used to diagnose Campylobacter abortions in sheep. 
Campylobacter antigens can also be detected by 
immunofluorescence. 
Bovine genital campylobacteriosis can be diagnosed by 
detecting specific IgA in the cervical mucus; these 
antibodies are present for several months in half of all 
infected cows. Tests include a vaginal mucus agglutination 
test (VMAT) and enzyme-linked immunosorbent assays 
(ELISAs). Individual responses in the VMAT are variable; 
for this test, a minimum of 10 cows or 10% of the herd 
should be sampled. Sheath washings taken twice from bulls, 
approximately one week apart, can be submitted for culture 
or immunofluorescent testing. Vaginal cultures can also be 
collected immediately after abortion or infection, but this 
method may be unreliable: Campylobacter fetus is fragile 
and usually present in low numbers. Systemic antibody 
responses are not useful in genital campylobacteriosis, as 
they can be directed against nonpathogenic species. A real-
time PCR assay has been developed to detect the causative 
organisms of bovine genital campylobacteriosis, including 
one that can differentiate C. fetus subsp. fetus and C. fetus 
subsp. venerealis. 
Treatment  
Many cases of campylobacteriosis are self-limiting and 
require only supportive therapy. Antibiotics may be useful 
for some cases of enteritis, especially those that are severe. 
Macrolides and fluoroquinolones are commonly prescribed 
for campylobacteriosis; however, resistance to these and 
other antibiotics also occurs. Treatment of healthy animals 
is not recommended for several reasons: there is a high 
likelihood of re-exposure and there is no evidence that 
treatment is effective. 
Antibiotic treatment may not completely prevent 
shedding in colonized animals, though it may prevent 
exposed sheep from aborting during an outbreak. Bulls with 
bovine genital campylobacteriosis are sometimes treated; 
cows usually are not, due to practical considerations. 
Prevention   
Chickens, particularly broilers, are the most frequently 
identified source of human exposure to Campylobacter. 
However, because the bacterium is ubiquitous, it is difficult 
to prevent colonization and infection in these birds. 
Numerous strategies have been explored to decrease 
colonization of poultry on the farm; however, none have been 
proven to reduce Campylobacter prevalence in broiler flocks. 
Generally, the implementation of strict biosecurity is 
recommended. Specific measures that have been suggested 
include use of insect control such as fly screens, rodent 
control, and footbaths. Changes in broiler production 
practices, such as restriction of slaughter age and 
discontinued thinning of broiler flocks, have also been 
investigated in Europe. Cross-contamination may be lessened 
by cleaning and decontamination of transport crates and other 
equipment used at slaughter. Because the surface of the 
carcasses can become contaminated during the slaughter 
process, methods to decrease the contamination of meat post-
slaughter have also been investigated.  
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There are few specific preventive measures for 
campylobacteriosis in other animals. Good hygiene, 
particularly in kennels and livestock housing, can reduce 
transmission. Avoidance of stress, such as crowding, may 
decrease shedding in carriers. Additionally, feeding raw 
meat to animals may increase the risk of infection.  
Vaccines are not available for enteritis, but can prevent 
abortions in sheep. They are also useful for both 
prophylaxis and treatment in bovine genital 
campylobacteriosis; however, vaccinated cows may remain 
carriers. Artificial insemination can control or prevent 
bovine genital campylobacteriosis. 
Morbidity and Mortality 
The prevalence of Campylobacter in poultry is variable 
(range 0–100%) and contamination of more than 50% of 
retail poultry meat is common in many parts of the world. 
In poultry, flock prevalence peaks in the summer months, 
although the reasons for this are still unclear.  
The prevalence of Campylobacter spp. in dogs and cats 
is generally high; up to 76% of healthy dogs and 58% of 
healthy cats have been identified as carriers in recent 
studies. Dogs and cats reared in intensive housing are more 
likely to be culture positive. However, the extent to which 
the bacterium causes enteritis in animals remains unclear. 
Some studies have found higher colonization rates in 
diarrheic animals, while others have found no difference. C. 
upsaliensis is currently the most commonly isolated species 
from dog feces.  
In other animals, there are limited studies on 
Campylobacter colonization. One recent study of Ohio 
dairy cattle showed that 37% of fecal samples were positive 
for Campylobacter spp., while another U.S. study detected 
the bacterium in 19% of fecal samples from cattle. In other 
countries, similar colonization rates have been detected.  
Gastrointestinal campylobacteriosis is usually self–
limiting in mammals; however, up to 32% mortality may be 
seen with highly pathogenic isolates in chicks. Mortality is 
also low in adult sheep and cattle affected by abortions and 
infertility. Morbidity may be up to 90% in outbreaks in 
sheep but is usually around 5–50%. 
Infections in Humans 
Incubation Period 
In humans, the incubation period for C. jejuni 
gastroenteritis is 1 to 10 days, and most often 2 to 5 days. 
The incubation period for human C. fetus infections is 
usually 3 to 5 days. 
Clinical Signs 
C. jejuni and occasionally C. coli cause enteritis; 
disease varies from mild gastrointestinal distress that 
resolves within 24 hours to a fulminating or relapsing 
colitis. Clinical infections are particularly common in 
immunosuppressed adults. The symptoms may include 
watery or sticky diarrhea, fever, nausea, vomiting, 
abdominal pain, headache and muscle pain. The feces may 
contain blood. Complications are not common; however, 
endocarditis, reactive arthritis, hemolytic uremic syndrome 
and septicemia are occasionally seen. Rare complications 
include meningitis, recurrent colitis, post-infectious irritable 
bowel syndrome, acute cholecystitis and Guillain–Barré 
syndrome (an acute, rapidly progressive, immune-mediated 
polyneuropathy that occurs in up to 30% of cases). Cases of 
C. jejuni abortion have been seen in humans, but are 
extremely rare. C. jejuni can also cause bacteremia, 
especially in the immunocompromised.  
C. fetus is an opportunistic human pathogen and mainly 
causes systemic infections. Infections tend to occur in people 
with debilitating illnesses such as HIV/AIDS, diabetes, 
cancer or cirrhosis. Intestinal symptoms may be mild. Fever 
is the only consistent sign, but abdominal pain, splenomegaly 
and hepatomegaly are common. Subacute endocarditis, septic 
arthritis, meningitis or fever of unknown origin are also seen. 
Complications may include endocarditis, pericarditis, 
pneumonia, thrombophlebitis, peritonitis or 
meningoencephalitis. C. fetus very rarely causes pre-term 
labor in pregnant women and neonatal sepsis.  
Other zoonotic Campylobacter spp. also cause illness 
in humans. C. lari has been isolated from children with 
mild diarrhea. C. upsaliensis is considered to be an 
emerging diarrheal pathogen and may also cause more 
serious disease. Bacteremia in immunocompromised 
individuals can be caused by C. hyointestinalis. C. fetus 
subsp. testudinum subsp. nov., which is associated with 
reptiles, can cause a variety of clinical signs in people who 
are immunocompromised.  
Diagnostic Tests 
As in animals, a presumptive diagnosis can be made 
by direct microscopic (e.g., darkfield) observation, and 
definitive diagnosis is by culture and identification. Feces 
or (rarely) blood cultures are used for diagnosis. PCR-
based techniques utilizing human stool enable rapid 
detection or culture confirmation. A number of serologic 
assays have been developed, but most are not available for 
routine diagnostic use.  
Treatment 
Treatment is often limited to fluid and electrolyte 
replacement therapy. Antibiotics are occasionally given, 
particularly when the symptoms are severe or prolonged; 
however, their use remains controversial for enteric 
infections, especially those that are mild. In 
immunocompromised people, including those with 
HIV/AIDS, antibiotic therapy is considered reasonable. 
Antibiotic treatment can reduce the shedding of infectious 
organisms. 
Antibiotic resistance is a significant problem for the 
treatment of Campylobacter infections in humans; as in 
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animals, multidrug resistance occurs. Worldwide, resistance 
to fluoroquinolones (e.g., ciprofloxacin) and tetracycline is 
most common. Macrolide resistance is also emerging in 
some areas. In the U.S., resistance to fluoroquinolones, 
tetracyclines, macrolides, and other antibiotics has been 
documented. Nearly 25% of tested isolates in the U.S. were 
resistant to ciprofloxacin in 2011.  
Antimotility drugs are contraindicated as they have 
been associated with prolonged symptoms and fatalities. 
Individuals with Guillain-Barré syndrome usually require 
intensive care. Vaccines are not available. 
Prevention  
As the handling, preparation, and consumption of food 
products is a risk factor for campylobacteriosis, proper food 
handling and preparation is a key component of prevention. 
Food preparers should wash their hands frequently, and 
keep counter tops, cutting boards, and utensils clean. 
Separate cutting boards and utensils should be used for 
animal products and other foods. All meat should be 
properly cooked and vegetables should be washed. 
Unpasteurized milk products and untreated water should 
not be consumed.  
Sick animals, such as puppies, kittens, or livestock, 
should be kept away from children. People who are 
immunocompromised, including pregnant women, should 
also limit contact with young animals and avoid all contact 
with animal feces. People who are ill with 
campylobacteriosis should practice good hygiene to prevent 
disease transmission to others.  
Those with occupational exposure to animals should 
wash their hands frequently after handling animals or 
animal feces. Workers should also avoid exposure to raw 
milk or other unpasteurized dairy products.  
Morbidity and Mortality 
C. jejuni is a common cause of bacterial diarrhea 
worldwide. However, many infections are undiagnosed or 
unreported, and surveillance programs are lacking in 
developing countries. In the United States, an estimated 
14.3 cases per 100,000 population occurred in 2012. In the 
European Union, the average incidence reported in 2009 
was 45.6 cases per 100,000 population. Models from 
China predict 161 cases per 100,000 population in urban 
areas and 37 cases per 100,000 population in rural areas. 
A high disease incidence also occurs in many other 
regions of the developing world. For example, 
Campylobacter are an important cause of traveler’s 
diarrhea in many regions including Southeast Asia, South 
Asia, and Africa. It has been estimated that 50–80% of 
strains infecting humans originate from chickens. The 
handling, preparation, and consumption of broiler meat, in 
particular, accounts for 20–30% of human cases of 
campylobacteriosis.  
Infections are particularly common in young children, 
and in young adults from age 18 to 29. As in poultry, 
human infections appear to be seasonal in developed 
countries, with late summer/early fall being most common. 
However, the reasons for this are unclear.  
C. jejuni or C. coli diarrhea is usually self-limiting, 
with or without specific therapy, and generally resolves 
after 7 to 10 days; relapses can occur in approximately 
10–25% of cases. Immunosuppressed individuals are at a 
high risk for severe or recurrent infections or for 
septicemia. Deaths are rare in C. jejuni infections and are 
seen mainly in patients with cancer or other debilitating 
diseases. The estimated case fatality ratio for C. jejuni 
infections is one in 1,000.  
Guillain-Barré syndrome is seen after approximately 1 
in 1000 diagnosed infections. A recent literature review 
showed that 31% of GBS cases were attributable to 
Campylobacter infection. Of those with GBS, 4–15% of 
patients may die, and 30% or more may have residual 
weakness or other neurologic defects. 
Campylobacteriosis can also be considered an 
occupational disease, as it has been documented in poultry 
processing workers. 
Internet Resources 
Campylobacter 
http://www.campylobacter.org 
Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/nczved/divisions/dfbmd/diseases/c
ampylobacter/  
Fight BAC: Partnership for Food Safety Education 
http://www.fightbac.org/  
Public Health Agency of Canada. Pathogen Safety Data 
Sheets and Risk Assessment 
http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-
eng.php  
The Merck Manual 
http://www.merckmanuals.com/professional/index.html  
The Merck Veterinary Manual 
http://www.merckmanuals.com/vet/index.html  
U.S. Department of Agriculture: Is It Done Yet? 
http://www.fsis.usda.gov/wps/portal/fsis/topics/food-
safety-education/teach-others/fsis-educational-
campaigns/is-it-done-yet  
U.S. FDA Foodborne Pathogenic Microorganisms and  
Natural Toxins Handbook (Bad Bug Book) 
http://www.fda.gov/Food/FoodborneIllnessContaminan
ts/CausesOfIllnessBadBugBook/  
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